Plasma level of lipopolysaccharide-binding protein is indicative of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

International Journal of Hematology, 05/08/2012

The study demonstrated that an elevated lipopolysaccharide–binding protein (LBP) level of >15000ng/ml may serve as a biomarker for the prediction and monitoring of Acute graft–versus–host disease (aGVHD).

Print Article Summary Cat 2 CME Report